Skip to main content
An official website of the United States government
Grant Details

Grant Number: 7U01CA249866-04 Interpret this number
Primary Investigator: Chatterjee, Nilanjan
Organization: Johns Hopkins University
Project Title: Multifactoral Breast Cancer Risk Prediction Accounting for Ethnic and Tumor Diversity
Fiscal Year: 2023


Abstract

Abstract Breast cancer risk assessment tools are widely used in clinical practice to guide decisions regarding screening timing and modality, life-style interventions, genetic testing, preventive therapy, and risk-reducing surgery. Although a number of tools are used in practice, they face various challenges including: (i) modest discriminatory ability due to lack of a unified model that incorporates a comprehensive set of risk-factors; (ii) inability to produce sub-type specific risk, especially considering aggressive subtypes of breast cancer and/or prophylactic endocrine therapy that is effective only for hormone receptor positive tumors; (iii) lack of data to build models for different ethnic populations; and, (iv) scant validation of models, especially in healthcare settings where models can be widely disseminated in practice. In this proposal, we will assimilate and analyze data on a large and diverse sample of women from studies participating in the NCI Cohort Consortium to develop a comprehensive tool that will predict breast cancer risk, overall and by sub-types, across major ethnic groups in the US. We further propose to prospectively validate the model in different clinical settings, including a risk-stratified screening trial. In Aim 1 we will develop a comprehensive model for predicting absolute risk of overall breast cancer for women from multiple ethnicities, incorporating information on family history; polygenic risk-scores (PRS); anthropometric, life-style and reproductive factors; hormonal biomarkers; and mammographic density. In Aim 2 we will tailor these risk models to specific breast cancer subtypes, notably estrogen receptor negative and positive cancers. In Aim 3 we will evaluate the validity of these risk prediction models in integrated health care systems, mammography registries, and an ongoing risk-based mammographic screening trial in the US. The resulting models could be used in diverse clinical settings to guide preventive therapy or risk-stratified screening programs, increasing the number of breast cancer deaths prevented while minimizing overdiagnosis and overtreatment.



Publications

Plasma proteomic comparisons change as coverage expands for SomaLogic and Olink.
Authors: Rooney M.R. , Chen J. , Ballantyne C.M. , Hoogeveen R.C. , Boerwinkle E. , Yu B. , Walker K.A. , Schlosser P. , Selvin E. , Chatterjee N. , et al. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2024-07-12 00:00:00.0; , .
EPub date: 2024-07-12 00:00:00.0.
PMID: 39040172
Related Citations

Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models.
Authors: Balasubramanian J.B. , Choudhury P.P. , Mukhopadhyay S. , Ahearn T. , Chatterjee N. , García-Closas M. , Almeida J.S. .
Source: Jamia Open, 2024 Jul; 7(2), p. ooae055.
EPub date: 2024-06-27 00:00:00.0.
PMID: 38938691
Related Citations

MUSSEL: Enhanced Bayesian polygenic risk prediction leveraging information across multiple ancestry groups.
Authors: Jin J. , Zhan J. , Zhang J. , Zhao R. , O'Connell J. , Jiang Y. , 23andMe Research Team , Buyske S. , Gignoux C. , Haiman C. , et al. .
Source: Cell Genomics, 2024-04-10 00:00:00.0; 4(4), p. 100539.
PMID: 38604127
Related Citations

Genetic Risk, Health-Associated Lifestyle, and Risk of Early-onset Total Cancer and Breast Cancer.
Authors: Zhang Y. , Lindström S. , Kraft P. , Liu Y. .
Source: Medrxiv : The Preprint Server For Health Sciences, 2024-04-06 00:00:00.0; , .
EPub date: 2024-04-06 00:00:00.0.
PMID: 38633776
Related Citations

Principles and methods for transferring polygenic risk scores across global populations.
Authors: Kachuri L. , Chatterjee N. , Hirbo J. , Schaid D.J. , Martin I. , Kullo I.J. , Kenny E.E. , Pasaniuc B. , Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium Methods Working Group , Witte J.S. , et al. .
Source: Nature Reviews. Genetics, 2024 Jan; 25(1), p. 8-25.
EPub date: 2023-08-24 00:00:00.0.
PMID: 37620596
Related Citations

Wasm-iCARE: a portable and privacy-preserving web module to build, validate, and apply absolute risk models.
Authors: Balasubramanian J.B. , Choudhury P.P. , Mukhopadhyay S. , Ahearn T. , Chatterjee N. , García-Closas M. , Almeida J.S. .
Source: Arxiv, 2023-10-13 00:00:00.0; , .
EPub date: 2023-10-13 00:00:00.0.
PMID: 37873020
Related Citations

Potential utility of risk stratification for multicancer screening with liquid biopsy tests.
Authors: Kim E.S. , Scharpf R.B. , Garcia-Closas M. , Visvanathan K. , Velculescu V.E. , Chatterjee N. .
Source: Npj Precision Oncology, 2023-04-22 00:00:00.0; 7(1), p. 39.
EPub date: 2023-04-22 00:00:00.0.
PMID: 37087533
Related Citations

Joint Modeling of Gene-Environment Correlations and Interactions using Polygenic Risk Scores in Case-Control Studies.
Authors: Wang Z. , Shi W. , Carroll R.J. , Chatterjee N. .
Source: Biorxiv : The Preprint Server For Biology, 2023-02-15 00:00:00.0; , .
EPub date: 2023-02-15 00:00:00.0.
PMID: 36824704
Related Citations

Polygenic risk scores for prediction of breast cancer in Korean women.
Authors: Jee Y.H. , Ho W.K. , Park S. , Easton D.F. , Teo S.H. , Jung K.J. , Kraft P. .
Source: International Journal Of Epidemiology, 2022-11-07 00:00:00.0; , .
EPub date: 2022-11-07 00:00:00.0.
PMID: 36343017
Related Citations

Validating Breast Cancer Risk Prediction Models in the Korean Cancer Prevention Study-II Biobank.
Authors: Jee Y.H. , Gao C. , Kim J. , Park S. , Jee S.H. , Kraft P. .
Source: Cancer Epidemiology, Biomarkers & Prevention : A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology, 2020 Jun; 29(6), p. 1271-1277.
EPub date: 2020-04-03 00:00:00.0.
PMID: 32245787
Related Citations




Back to Top